Press Releases Ketamine - PharmaTher Holdings Ltd. Ketamine

OTCQB: PHRRF | CSE: PHRM

HOME
COMPANY
- Management
- Board Of Directors
PRODUCTS
- KetaVault
- KETARX Ketamine
INVESTORS
NEWS
CONTACT

HOME
COMPANY
- Management
- Board Of Directors
PRODUCTS
- KetaVault
- KETARX Ketamine
INVESTORS
NEWS
CONTACT

Press Releases

5/16/2025

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

5/14/2025

PharmaTher Unveils KetaVault™: A First-of-Its-Kind Portal to Accelerate Ketamine Research and Commercialization

3/11/2025

PharmaTher Receives US FDA Approval Goal Date for Ketamine

3/3/2025

PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine

2/12/2025

PharmaTher Provides Update on FDA New Drug Application for Ketamine

1/6/2025

PharmaTher CEO Issues Letter to Shareholders

11/26/2024

PharmaTher Announces Update on FDA New Drug Application for Ketamine

11/19/2024

PharmaTher Announces Update on FDA New Drug Application for Ketamine

11/13/2024

PharmaTher Announces Post Complete Response Letter Clarification Meeting Request Granted from the FDA for Ketamine Abbreviated New Drug Application

10/23/2024

PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application

Archives

May 2025
March 2025
February 2025
January 2025
November 2024
October 2024
September 2024
August 2024
May 2024
April 2024
February 2024
January 2024
September 2023
July 2023
June 2023
May 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020

Categories

© COPYRIGHT 2025. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.